Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SolesenceSLSN +1.26%53 12-1 Month Momentum % is -78.57% as of Aug. 01, 2026. GuruFocus rates SLSN with a GF Score™ of 53/100 and a GF Value™ of $1.77 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 2,022 Consumer Packaged Goods companies, Solesence ranks worse than 98.37% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-01), Solesence's 12-1 Month Momentum % is -78.57%.
The industry rank for Solesence's 12-1 Month Momentum % or its related term are showing as below:
SLSN's 12-1 Month Momentum % is ranked worse than 98.37% of 2022
companies
in the Consumer Packaged Goods industry
Industry Median: -8.945
vs SLSN: -78.57
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Solesence 12-1 Month Momentum % Related Terms
SLSN vs GROV, SKIN, UG: 12-1 Month Momentum % Comparison
For the Household & Personal Products subindustry, Solesence's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solesence 12-1 Month Momentum % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Solesence's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Solesence's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -78.57% mean?
Solesence (SLSN) has a 12-1 Month Momentum % of -78.57% as of Aug. 01, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Solesence and its competitors. According to the industry distribution chart, Solesence ranks #1989 out of 2022 companies in the Consumer Packaged Goods industry, placing it in the top 98.4%.
Is Solesence's 12-1 Month Momentum % too high?
Solesence's current 12-1 Month Momentum % is -78.57%. Based on the distribution chart, Solesence ranks #1989 out of 2022 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Solesence has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Solesence's 12-1 Month Momentum % compare to GROV and SKIN?
According to the Consumer Packaged Goods industry distribution chart, Solesence ranks #1989 out of 2022 companies for 12-1 Month Momentum %. This places Solesence in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Consumer Packaged Goods company?
A good 12-1 Month Momentum % depends on the Consumer Packaged Goods industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Solesence and its competitors. Solesence's current 12-1 Month Momentum % is -78.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solesence stock overvalued right now?
Based on GuruFocus' analysis, Solesence (SLSN) is currently considered Possible Value Trap. The stock's GF Value™ is $1.77, compared to a current price of $0.83 — trading 53.1% below its estimated fair value. The current 12-1 Month Momentum % is -78.57%. Solesence's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Solesence (SLSN), the current 12-1 Month Momentum % is -78.57% as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Solesence (SLSN) Overvalued in 2026?
Based on GuruFocus' analysis, Solesence stock appears to be undervalued.
The current stock price of $0.83 is trading 53.1% below its estimated GF Value™ of $1.77.
GuruFocus considers Solesence to be Possible Value Trap.
Key valuation signals for SLSN:
12-1 Month Momentum %: -78.57%
GF Value™: $1.77 vs. price of $0.83 (53.1% below fair value)
No single metric tells the full story. See the SLSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Solesence Inc is a health-oriented, science-driven company, focused on various skin health, beauty and wellness markets. Its primary skin health products are fully developed prestige skin care formulations with mineral-based UV protection enabled by proprietary Active Pharmaceutical Ingredients, which are also marketed as APIs for sale to manufacturers of other types of skin health products, including sunscreens and daily care products. Additionally, it continues to sell products in legacy markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. The company operates as a single business segment.
53GF Score
Get the complete analysis for SLSN
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SLSN has been successfully added to your 
